UCB and Veeva Announce Collaboration
Veeva Systems has announced a collaboration with UCB, whereby the pharma company will adopt Veeva's ePRO and eConsent solutions, to provide a patient-centric, digital experience to study participants.
Veeva ePRO offers the design, management, and completion of electronic patient-reported outcomes (ePRO) with data flow among sponsors, sites, and patients. Veeva eConsent offers the set-up, completion, and review of consent for patients, sites, and study teams. Both applications are available to patients through MyVeeva for Patients, which provides access for participants clinical trial activities, scheduling, and communications. Veeva ePRO and Veeva eConsent are part of Veeva Vault Clinical Suite, a set of integrated capabilities for both clinical operations and clinical data management.
Reference
UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials. (May 23, 2023). Cision PR Newswire.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
